US Patent Issued to Abbott Diabetes Care on July 22 for "Mitigating single point failure of devices in an analyte monitoring system and methods thereof" (California Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,419, issued on July 22, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Mitigating single point failure of devices in an analyte monitoring system and methods thereof" was invented by Gary Alan Hayter (Oakland, Calif.) and Marc Barry Taub (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, devices, and kits are provided for mitigating single point failure of at least one device in an analyte monitoring system."

The patent was filed on Feb. 19, 2021, under Application No. 17/179,635.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P...